{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:07:42Z","timestamp":1792789662352,"version":"4.5.0"},"reference-count":58,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Beijing municipal natural science foundation","award":["20SWAQK22"],"award-info":[{"award-number":["20SWAQK22"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Pulmonary fibrosis (PF) is one of the sequelae of Corona Virus Disease 2019 (COVID-19), and currently, lung transplantation is the only viable treatment option. Hence, other effective treatments are urgently required. We investigated the therapeutic effects of an approved botanical drug, cepharanthine (CEP), in a cell culture model of transforming growth factor-\u03b21 (TGF-\u03b21) and bleomycin (BLM)-induced pulmonary fibrosis rat models both in vitro and in vivo. In this study, CEP and pirfenidone (PFD) suppressed BLM-induced lung tissue inflammation, proliferation of blue collagen fibers, and damage to lung structures in vivo. Furthermore, we also found increased collagen deposition marked by \u03b1-smooth muscle actin (\u03b1-SMA) and Collagen Type I Alpha 1 (COL1A1), which was significantly alleviated by the addition of PFD and CEP. Moreover, we elucidated the underlying mechanism of CEP against PF in vitro. Various assays confirmed that CEP reduced the viability and migration and promoted apoptosis of myofibroblasts. The expression levels of myofibroblast markers, including COL1A1, vimentin, \u03b1-SMA, and Matrix Metallopeptidase 2 (MMP2), were also suppressed by CEP. Simultaneously, CEP significantly suppressed the elevated Phospho-NF-\u03baB p65 (p-p65)\/NF-\u03baB p65 (p65) ratio, NOD-like receptor thermal protein domain associated protein 3 (NLRP3) levels, and elevated inhibitor of NF-\u03baB Alpha (I\u03baB\u03b1) degradation and reversed the progression of PF. Hence, our study demonstrated that CEP prevented myofibroblast activation and treated BLM-induced pulmonary fibrosis in a dose-dependent manner by regulating nuclear factor kappa-B (NF-\u03baB)\/ NLRP3 signaling, thereby suggesting that CEP has potential clinical application in pulmonary fibrosis in the future.<\/jats:p>","DOI":"10.3390\/molecules28020753","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T03:47:01Z","timestamp":1673495221000},"page":"753","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-\u03baB\/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7281-6530","authenticated-orcid":false,"given":"Guangrui","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqiu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8993-0436","authenticated-orcid":false,"given":"Di","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyun","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuona","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taoyun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolan","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifang","family":"Dou","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e1086","DOI":"10.1002\/cti2.1086","article-title":"Idiopathic and immune-related pulmonary fibrosis: Diagnostic and therapeutic challenges","volume":"8","author":"Moore","year":"2019","journal-title":"Clin. Transl. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1378\/chest.09-1002","article-title":"Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: A population-based study","volume":"137","author":"Daniels","year":"2010","journal-title":"Chest"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ccm.2011.12.001","article-title":"Idiopathic pulmonary fibrosis: Diagnosis and epidemiology","volume":"33","author":"Olson","year":"2012","journal-title":"Clin. Chest Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.rmed.2011.08.022","article-title":"Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis","volume":"105","author":"Navarro","year":"2011","journal-title":"Respir. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1513\/pats.200512-131TK","article-title":"Is idiopathic pulmonary fibrosis an environmental disease?","volume":"3","author":"Taskar","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"de Rooij, L., Becker, L.M., Teuwen, L.A., Boeckx, B., Jansen, S., Feys, S., Verleden, S., Liesenborghs, L., Stalder, A.K., and Libbrecht, S. (2022). The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single cell resolution. Cardiovasc. Res., cvac 139.","DOI":"10.1093\/cvr\/cvac139"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"King","year":"2011","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.matbio.2018.03.021","article-title":"Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets","volume":"71\u201372","author":"Hewlett","year":"2018","journal-title":"Matrix Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1164\/rccm.201312-2221PP","article-title":"Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. An integral model","volume":"189","author":"Selman","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic Pulmonary Fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","article-title":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: A prospective cohort study","volume":"395","author":"Cummings","year":"2020","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e20190103","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-beta in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"180033","DOI":"10.1183\/16000617.0033-2018","article-title":"Matrix abnormalities in pulmonary fibrosis","volume":"27","author":"Upagupta","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41419-019-1873-x","article-title":"Transforming growth factor (TGF)-beta1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis","volume":"10","author":"Wei","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.3748\/wjg.v20.i23.7260","article-title":"Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update","volume":"20","author":"Elpek","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1535370219898141","article-title":"Mechanisms of liver fibrosis and its role in liver cancer","volume":"245","author":"Dhar","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12931-020-1300-y","article-title":"Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-beta-induced fibroblast to myofibroblast differentiation","volume":"21","author":"Liu","year":"2020","journal-title":"Respir. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1164\/rccm.201106-0965OC","article-title":"Regulation of transforming growth factor-beta1-driven lung fibrosis by galectin-3","volume":"185","author":"Mackinnon","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jep.2014.04.024","article-title":"Ethnobotany, phytochemistry and pharmacology of Stephania rotunda Lour","volume":"154","author":"Desgrouas","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13002-015-0019-1","article-title":"Ethnobotanical study on medicinal plants used by Maonan people in China","volume":"11","author":"Hong","year":"2015","journal-title":"J. Ethnobiol. Ethnomed."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1021\/np400084t","article-title":"Cytotoxic bisbenzylisoquinoline alkaloids from Stephania epigaea","volume":"76","author":"Lv","year":"2013","journal-title":"J. Nat. Prod."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"152956","DOI":"10.1016\/j.phymed.2019.152956","article-title":"Cepharanthine: An update of its mode of action, pharmacological properties and medical applications","volume":"62","author":"Bailly","year":"2019","journal-title":"Phytomedicine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10753-013-9744-6","article-title":"Cepharanthine attenuates lipopolysaccharide-induced mice mastitis by suppressing the NF-kappaB signaling pathway","volume":"37","author":"Ershun","year":"2014","journal-title":"Inflammation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.intimp.2012.04.015","article-title":"Low dose cepharanthine ameliorates immune thrombocytopenic purpura associated with multiple myeloma","volume":"13","author":"Tabata","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/a-0706-7503","article-title":"Mechanism of Cepharanthine Cytotoxicity in Human Ovarian Cancer Cells","volume":"85","author":"Payon","year":"2019","journal-title":"Planta Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41422-021-00581-y","article-title":"Comparison of viral RNA-host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2","volume":"32","author":"Zhang","year":"2022","journal-title":"Cell Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/bib\/bbaa387","article-title":"Transcriptome analysis of cepharanthine against a SARS-CoV-2-related coronavirus","volume":"22","author":"Li","year":"2021","journal-title":"Brief. Bioinform."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"105143","DOI":"10.1016\/j.antiviral.2021.105143","article-title":"Inhibition of herpes simplex virus 1 by cepharanthine via promoting cellular autophagy through up-regulation of STING\/TBK1\/P62 pathway","volume":"193","author":"Liu","year":"2021","journal-title":"Antivir. Res."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Li, J., Chen, G., Meng, Z., Wu, Z., Gan, H., Zhu, X., Han, P., Liu, T., Wang, F., and Gu, R. (2022). Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection. Molecules, 27.","DOI":"10.3390\/molecules27092745"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.biopha.2017.04.009","article-title":"Nigella sativa, a traditional Tunisian herbal medicine, attenuates bleomycin-induced pulmonary fibrosis in a rat model","volume":"90","author":"Abidi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/1874467214666210204212533","article-title":"Ticagrelor Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by the Inhibition of TGF-beta1\/Smad3 and PI3K\/AKT\/mTOR Pathways","volume":"15","author":"Wanas","year":"2022","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1016\/j.apsb.2022.04.006","article-title":"LncRNA DACH1 protects against pulmonary fibrosis by binding to SRSF1 to suppress CTNNB1 accumulation","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report","volume":"194","author":"Collard","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"153298","DOI":"10.1016\/j.phymed.2020.153298","article-title":"Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-beta mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems","volume":"78","author":"Andugulapati","year":"2020","journal-title":"Phytomedicine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fimmu.2018.00271","article-title":"Histopathological Correlations between Mediastinal Fat-Associated Lymphoid Clusters and the Development of Lung Inflammation and Fibrosis following Bleomycin Administration in Mice","volume":"9","author":"Elewa","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.15420\/cfr.2021.30","article-title":"Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond","volume":"8","author":"Aimo","year":"2022","journal-title":"Card. Fail. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e141618","DOI":"10.1172\/jci.insight.141618","article-title":"Loss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis","volume":"6","author":"Redente","year":"2020","journal-title":"JCI Insight"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/annrheumdis-2014-206234","article-title":"Tribbles homologue 3 stimulates canonical TGF-beta signalling to regulate fibroblast activation and tissue fibrosis","volume":"75","author":"Tomcik","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ymthe.2020.09.031","article-title":"Targeting FSTL1 for Multiple Fibrotic and Systemic Autoimmune Diseases","volume":"29","author":"Li","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3892\/mmr.2017.6711","article-title":"Maresin 1 inhibits transforming growth factor-beta1-induced proliferation, migration and differentiation in human lung fibroblasts","volume":"16","author":"Sun","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"102367","DOI":"10.1016\/j.isci.2021.102367","article-title":"Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment","volume":"24","author":"Ohashi","year":"2021","journal-title":"iScience"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"110151","DOI":"10.1016\/j.biopha.2020.110151","article-title":"Cepharanthine attenuates cerebral ischemia\/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12\/15-LOX signaling","volume":"127","author":"Zhao","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"854239","DOI":"10.3389\/fphar.2022.854239","article-title":"Cepharanthine Ameliorates Chondrocytic Inflammation and Osteoarthritis via Regulating the MAPK\/NF-kappaB-Autophagy Pathway","volume":"13","author":"Yao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10753-013-9734-8","article-title":"Cepharanthine, an alkaloid from Stephania cepharantha Hayata, inhibits the inflammatory response in the RAW264.7 cell and mouse models","volume":"37","author":"Huang","year":"2014","journal-title":"Inflammation"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1901105","DOI":"10.1183\/13993003.01105-2019","article-title":"The importance of interventional timing in the bleomycin model of pulmonary fibrosis","volume":"55","author":"Kolb","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1165\/rcmb.2017-0096ST","article-title":"An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis","volume":"56","author":"Jenkins","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_49","first-page":"1","article-title":"Melatonin ameliorates bleomycin-induced pulmonary fibrosis via activating NRF2 and inhibiting galectin-3 expression","volume":"4","author":"Lan","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12931-022-02192-6","article-title":"Human umbilical cord mesenchymal stem cells combined with pirfenidone upregulates the expression of RGS2 in the pulmonary fibrosis in mice","volume":"23","author":"Wu","year":"2022","journal-title":"Respir. Res."},{"key":"ref_51","first-page":"00247","article-title":"Niclosamide-loaded nanoparticles (Ncl-NPs) reverse pulmonary fibrosis in vivo and in vitro","volume":"1232","author":"Gan","year":"2022","journal-title":"J. Adv. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e1099","DOI":"10.1002\/ctm2.1099","article-title":"Blockade of the pentraxin 3\/CD44 interaction attenuates lung injury-induced fibrosis","volume":"12","author":"Chi","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Kuga, K., Kusakari, Y., Uesugi, K., Semba, K., Urashima, T., Akaike, T., and Minamisawa, S. (2020). Fibrosis growth factor 23 is a promoting factor for cardiac fibrosis in the presence of transforming growth factor-beta1. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0231905"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.7150\/ijbs.57247","article-title":"NEDD4L-induced beta-catenin ubiquitination suppresses the formation and progression of interstitial pulmonary fibrosis via inhibiting the CTHRC1\/HIF-1alpha axis","volume":"17","author":"Chen","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/13510002.2022.2096339","article-title":"Sevoflurane reduces lipopolysaccharide-induced apoptosis and pulmonary fibrosis in the RAW264.7 cells and mice models to ameliorate acute lung injury by eliminating oxidative damages","volume":"27","author":"Zheng","year":"2022","journal-title":"Redox Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12931-022-02167-7","article-title":"IL-37 protects against airway remodeling by reversing bronchial epithelial-mesenchymal transition via IL-24 signaling pathway in chronic asthma","volume":"23","author":"Feng","year":"2022","journal-title":"Respir. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1033919","DOI":"10.3389\/fphar.2022.1033919","article-title":"Yiqi Huayu decoction alleviates bleomycin-induced pulmonary fibrosis in rats by inhibiting senescence","volume":"13","author":"Zuo","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12967-022-03597-z","article-title":"Lumican is elevated in the lung in human and experimental acute respiratory distress syndrome and promotes early fibrotic responses to lung injury","volume":"20","author":"Wang","year":"2022","journal-title":"J. Transl. Med."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/2\/753\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:03:40Z","timestamp":1760119420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/2\/753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,11]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["molecules28020753"],"URL":"https:\/\/doi.org\/10.3390\/molecules28020753","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,11]]}}}